A practical guide to basal cell carcinoma
Basal cell carcinoma (BCC) is the most common form of cancer in humans. Skin cancers are divided into two groups: non-melanoma skin cancer (NMSC) and melanoma. Within the NMSC group, BCC accounts for 75–80% of cases and the remainder are predominantly squamous cell carcinomas (SCC). It is difficult to know the exact incidence due to underreporting of BCC in cancer registries. There were around 132,000 new cases of non-melanoma skin cancer in the UK in 2014, though this underestimates the true incidence. However, the incidence of BCC in Europe has increased by approximately 5% annually over recent decades, and in the USA rates have increased by 2% annually. This increasing incidence of BCC is impacting on healthcare services.
Dermatology in practice 2017; 23(2): 46–50
To continue reading this article, please sign in or register.